Trial Profile
Investigation of a single dose of Staccato alprazolam for inhalation on doxapram-induced panic attack in patients with panic disorder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Alprazolam (Primary)
- Indications Panic disorder
- Focus Therapeutic Use
- Sponsors Alexza Pharmaceuticals
- 03 Jun 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 30 Apr 2008 Status changed to in progress as reported by Alexza Pharmaceuticals.
- 24 Apr 2006 New trial record.